Education
University of North Carolina at Chapel Hill
Postdoctoral Fellowship, Pulmonary Drug Development 2006-01-01 - 2007-12-01University of North Carolina at Chapel Hill
PhD, Cell and Developmental Biology 2000-01-01 - 2006-01-01University of Tennessee, Knoxville
BS, Biochemistry, Cell Biology, Molecular Biology 1997-01-01 - 2000-01-01Bearden High School
, -Work Experience
Aer Therapeutics, Inc.
Current
Aer Therapeutics, Inc.
Altis Biosystems
2021-03-01 - 2024-02-01
Altis Biosystems
Parion Sciences
2008-01-01 - 2021-03-01
Parion Sciences
The Coca-Cola Company
2007-01-01 - 2008-01-01
The Coca-Cola Company
University of North Carolina at Chapel Hill
2000-08-01 - 2006-01-01
University of North Carolina at Chapel Hill
Skills
Summary
As the Chief Scientific Officer at Altis Biosystems, I lead the research and development of novel drug candidates and the creation of physiologically relevant pre-clinical models for various diseases. With over 16 years of experience in the pharmaceutical and biotechnology industries, I have a proven track record of building and managing cross-functional R&D teams, securing NIH grant funding, and establishing external partnerships with leading pharmaceutical companies. I have raised >$30 million in NIH grants and leveraged this federal funding into $100 million in of external partnerships. My core competencies include cell biology, drug development, and clinical development, with a focus on pulmonary and ophthalmic therapeutics. I am passionate about translating scientific discoveries into innovative solutions that can improve the lives of patients.